9vyj: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 9vyj is ON HOLD | The entry 9vyj is ON HOLD | ||
Authors: Yan, J., Feng, Y., Feng, Y.J. | Authors: Yan, J., Feng, Y., Feng, Y.J. | ||
| Line 7: | Line 7: | ||
Description: The top priority ESKAPE pathogens deploy flexible Sir2-HerA systems for anti-phage defense | Description: The top priority ESKAPE pathogens deploy flexible Sir2-HerA systems for anti-phage defense | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Feng, Y]] | |||
[[Category: Yan, J]] | |||
[[Category: Feng, Y.J]] | [[Category: Feng, Y.J]] | ||
Latest revision as of 08:59, 15 April 2026
Unreleased structure
The entry 9vyj is ON HOLD
Authors: Yan, J., Feng, Y., Feng, Y.J.
Description: The top priority ESKAPE pathogens deploy flexible Sir2-HerA systems for anti-phage defense
